Antisense Therapeutics: Raises $7.3M for DMD treatment
Antisense Therapeutics (ANP) has raised $7.3 million for its Duchenne muscular dystrophy (DMD) treatment
The company will issue 73 million shares at 10...
© 2026 FintechInshorts. All Rights Reserved.

